Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic- Associated Fatty Liver Disease (MAFLD)”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Not applicableUnknownNCT06503068
What this trial is testing

Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients

Who this might be right for
NAFLD
Tanta University 500
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Not applicableUnknownNCT05421572
What this trial is testing

Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver Disease
Beijing Tsinghua Chang Gung Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06798948
What this trial is testing

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

Who this might be right for
Metabolic-associated Fatty Liver Disease (MAFLD)
Li Lab,MD 100
Post-approval studies (Phase 4)UnknownNCT05140694
What this trial is testing

Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D

Who this might be right for
Metabolic-associated Fatty Liver DiseaseType 2 Diabetes
Seoul National University Bundang Hospital 135
Not applicableStudy completedNCT06537882
What this trial is testing

Evaluate the Effect of Synbiotics on MAFLD

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease
GenieBiome Limited 54
Not applicableNot Yet RecruitingNCT06135584
What this trial is testing

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseCirrhosis
The Affiliated Hospital of Hangzhou Normal University 1,000
Not applicableUnknownNCT05520697
What this trial is testing

Exercise and Cerebral Hemodynamics in MAFLD.

Who this might be right for
Non-alcoholic Fatty Liver Disease
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Not applicableUnknownNCT05880316
What this trial is testing

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

Who this might be right for
Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 100
Not applicableNot Yet RecruitingNCT07284004
What this trial is testing

Fatty Liver in Long Standing Cholecystectomy

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Post-cholecystectomy Metabolic Changes -Hepatic Steatosis
Yasmeen Ahmed Farrag Ahmed 100
Not applicableStudy completedNCT07297225
What this trial is testing

Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model

Who this might be right for
MAFLDCholecystitisGallbladder Polyps+1 more
Zhujiang Hospital 150
Not applicableStudy completedNCT05778266
What this trial is testing

Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver DiseaseObesity, AdolescentArterial Stiffness
Universidad de Guanajuato 43
Not applicableLooking for participantsNCT06585982
What this trial is testing

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

Who this might be right for
Fatty Liver Disease
Universitas Diponegoro 50
Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Not applicableNot Yet RecruitingNCT07373769
What this trial is testing

Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of British Columbia 145
Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750
What this trial is testing

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD

Who this might be right for
T2DMMAFLD
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Not applicableUnknownNCT04871880
What this trial is testing

Lifestyle Modification for MAFLD Based on TTM

Who this might be right for
Metabolic Associated Fatty Liver Disease
Nanfang Hospital, Southern Medical University 75
Not applicableStudy completedNCT04551716
What this trial is testing

Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population

Who this might be right for
Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
Chinese PLA General Hospital 448
Not applicableActive Not RecruitingNCT06983171
What this trial is testing

Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice

Who this might be right for
MAFLD
Center of target therapy 70
Next Page